1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Metagenomics Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Metagenomics Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Venture Capital Investments
- 5.1.2 Advantages of Metagenomics in Biotechnology
- 5.1.3 Industrial Applications of Metagenomics
5.2 Market Opportunities
- 5.2.1 Usage of Metagenomics for Precision Medicine
5.3 Future Trends
- 5.3.1 Extensive Set Of Molecular- Based Approaches
5.4 Impact of Drivers and Restraints
6. Europe Metagenomics Market Regional Analysis
6.1 Europe Metagenomics Market Overview
6.2 Europe Metagenomics Market Revenue 2016-2027 (US$ Million)
6.3 Europe Metagenomics Market Forecast Analysis
7. Europe Metagenomics Market Analysis – by Product
7.1 Instruments & Software and Consumables
- 7.1.1 Overview
- 7.1.2 Instruments & Software and Consumables: Europe Metagenomics Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Metagenomics Market Analysis – by Application
8.1 Clinical Diagnostics
- 8.1.1 Overview
- 8.1.2 Clinical Diagnostics: Europe Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Drug Discovery Metagenomics
- 8.2.1 Overview
- 8.2.2 Drug Discovery Metagenomics: Europe Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)
9. Europe Metagenomics Market – Europe Analysis
9.1 Europe
- 9.1.1 Europe Metagenomics Market Breakdown, by Key
Country, 2019 and 2027 (%)
- 9.1.1.1 Europe Metagenomics Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 UK:
Europe Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.1.1 UK: Europe Metagenomics Market Breakdown, by Product
- 9.1.1.1.2 UK: Europe Metagenomics Market Breakdown, by Application
- 9.1.1.2 Germany:
Europe Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.2.1 Germany: Europe Metagenomics Market Breakdown, by Product
- 9.1.1.2.2 Germany: Europe Metagenomics Market Breakdown, by Application
- 9.1.1.3 France:
Europe Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.3.1 France: Europe Metagenomics Market Breakdown, by Product
- 9.1.1.3.2 France: Europe Metagenomics Market Breakdown, by Application
- 9.1.1.4 Russia:
Europe Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.4.1 Russia: Europe Metagenomics Market Breakdown, by Product
- 9.1.1.4.2 Russia: Europe Metagenomics Market Breakdown, by Application
- 9.1.1.5 Italy:
Europe Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.5.1 Italy: Europe Metagenomics Market Breakdown, by Product
- 9.1.1.5.2 Italy: Europe Metagenomics Market Breakdown, by Application
- 9.1.1.6 Rest of Europe:
Europe Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.6.1 Rest of Europe: Europe Metagenomics Market Breakdown, by Product
- 9.1.1.6.2 Rest of Europe: Europe Metagenomics Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Europe Metagenomics Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Merck KGaA
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Thermo Fisher Scientific Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Agilent Technologies
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Qiagen
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Bio-Rad Laboratories, Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Perkinelmer Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Illumina Inc.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 F Hoffman-La Roche Ltd.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Oxford Nanopore Technologies Ltd.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Pacific Bioscience of California, Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For Europe Metagenomics Market
